These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15053281)

  • 1. A cost-benefit analysis of testing for influenza A in high-risk adults.
    Hueston WJ; Benich JJ
    Ann Fam Med; 2004; 2(1):33-40. PubMed ID: 15053281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of newer treatment strategies for influenza.
    Smith KJ; Roberts MS
    Am J Med; 2002 Sep; 113(4):300-7. PubMed ID: 12361816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.
    Rothberg MB; Bellantonio S; Rose DN
    Ann Intern Med; 2003 Sep; 139(5 Pt 1):321-9. PubMed ID: 12965940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of influenza symptoms in healthy adults.
    Rothberg MB; He S; Rose DN
    J Gen Intern Med; 2003 Oct; 18(10):808-15. PubMed ID: 14521643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral agents for influenza: a comparison of cost-effectiveness data.
    Lynd LD; Goeree R; O'Brien BJ
    Pharmacoeconomics; 2005; 23(11):1083-106. PubMed ID: 16277546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic testing or empirical neuraminidase inhibitor therapy for patients with influenza-like illness: what a difference a day makes.
    Blitz SG; Cram P; Chernew ME; Monto AS; Fendrick AM
    Am J Manag Care; 2002 Mar; 8(3):221-7. PubMed ID: 11915972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults.
    Lee PY; Matchar DB; Clements DA; Huber J; Hamilton JD; Peterson ED
    Ann Intern Med; 2002 Aug; 137(4):225-31. PubMed ID: 12186512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oseltamivir Treatment for Children with Influenza-Like Illness in China: A Cost-Effectiveness Analysis.
    Shen K; Xiong T; Tan SC; Wu J
    PLoS One; 2016; 11(4):e0153664. PubMed ID: 27082431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of influenza symptoms in healthy children: cost-effectiveness of rapid testing and antiviral therapy.
    Rothberg MB; Fisher D; Kelly B; Rose DN
    Arch Pediatr Adolesc Med; 2005 Nov; 159(11):1055-62. PubMed ID: 16275797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-utility of rapid polymerase chain reaction-based influenza testing for high-risk emergency department patients.
    Dugas AF; Coleman S; Gaydos CA; Rothman RE; Frick KD
    Ann Emerg Med; 2013 Jul; 62(1):80-8. PubMed ID: 23522607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.
    Turner D; Wailoo A; Nicholson K; Cooper N; Sutton A; Abrams K
    Health Technol Assess; 2003; 7(35):iii-iv, xi-xiii, 1-170. PubMed ID: 14609480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysis.
    Schwarzinger M; Housset B; Carrat F
    Pharmacoeconomics; 2003; 21(3):215-24. PubMed ID: 12558471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oseltamivir for treatment of influenza in healthy adults: pooled trial evidence and cost-effectiveness model for Canada.
    O'Brien BJ; Goeree R; Blackhouse G; Smieja M; Loeb M
    Value Health; 2003; 6(2):116-25. PubMed ID: 12641862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza: evolving strategies in treatment and prevention.
    Lynch JP; Walsh EE
    Semin Respir Crit Care Med; 2007 Apr; 28(2):144-58. PubMed ID: 17458769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treat or test first? Decision analysis of empirical antiviral treatment of influenza virus infection versus treatment based on rapid test results.
    Sintchenko V; Gilbert GL; Coiera E; Dwyer D
    J Clin Virol; 2002 Jul; 25(1):15-21. PubMed ID: 12126717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral therapy for influenza : a clinical and economic comparative review.
    Schmidt AC
    Drugs; 2004; 64(18):2031-46. PubMed ID: 15341496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States.
    Talbird SE; Brogan AJ; Winiarski AP; Sander B
    Am J Health Syst Pharm; 2009 Mar; 66(5):469-80. PubMed ID: 19233995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of rapid tests for individual diagnosis of influenza].
    Uphoff H; Metzger C
    Dtsch Med Wochenschr; 2002 May; 127(20):1096-101. PubMed ID: 12016558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summaries for patients. Cost-effective management of flu in adults older than 65 years of age.
    Ann Intern Med; 2003 Sep; 139(5 Pt 1):I27. PubMed ID: 12965955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.